WEDNESDAY, June 25, 2025 (HealthDay News) -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell lymphoma ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- For women with breast cancer (BC), BRCA mutations are associated with increased risk of developing breast implant–associated anaplastic large cell ...

Roche has demonstrated the power of combining two of oncology’s hottest modalities—bispecifics and antibody-drug conjugates (ADCs)—in a Lunsumio-Polivy regimen in large B-cell lymphoma (LBCL ...

“We believe that these data support the use of Glofit-GemOx as a preferred second-line treatment option, which offers patients with nontransplant eligible, diffuse large B-cell lymphoma access ...

It's possible that implant-associated lymphoma is yet another cancer that can arise because of these genetic mutations." Paola Ghione, MD, lead researcher, lymphoma specialist at Memorial Sloan ...

Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma Provided by PR Newswire Jun 13, 2025, 8:00:00 AM ...

Breast cancer patients with BRCA mutations and textured implants found to have increased risk of rare lymphoma by American Society of Hematology ...

Beloved Australian actor, Magda Szubanski, has revealed she's been diagnosed with a "very rare, very aggressive, very serious" blood cancer called mantle cell lymphoma.

7078Background: Anaplastic lymphoma kinase positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare subtype of peripheral T-cell lymphoma, characterized by CD 30+ large pleomorphic lymphoid cells ...

Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form of T-cell lymphoma that usually occurs in children and young adults.